Home / Transcripts / NewLake Capital Partners, Inc. (NLCP) · March 6, 2026

NewLake Capital Partners, Inc. (NLCP) Earnings Call Transcript

March 6, 2026

OTC Pink Market US Real Estate Industrial REITs earnings 33 min

Earnings Call Speaker Segments

Jack Perkins executive
#1

Thanks, operator, and good morning to all of you. With me on the call are our Chairman, Gordon DuGan; Anthony Coniglio, who serves as President and Chief Executive Officer; and Lisa Meyer, our Chief Financial Officer. Before we get started, I want to remind you that some of what we say today could be viewed as forward-looking statements under the safe harbor provisions contained in the Private Securities Litigation Reform Act of 1995. A variety of risks and uncertainties could cause actual results to differ materially. We'll also be discussing non-GAAP measures, among them FFO and AFFO. You can find reconciliations to the most directly comparable GAAP measures in our earnings release. Having said that, I'll hand things over to Gordon DuGan, our Chairman.

Gordon DuGan executive
#2

Thanks, Jack, and good morning to all of you. We're quite happy with how we did in the fourth quarter and across the whole of 2025, especially given conditions that continue to be difficult for the cannabis sector, with capital still hard to come by and operators executing inconsistently. Over the year, revenue came to $51 million, AFFO reached $44 million, and we paid out $1.72 per share in dividends out of $2.09 per share of AFFO, which really shows the cash flow our business produces. Since our 2021 IPO, dividends paid total $6.86 per share. Our team stays committed to rigorous risk management, finding new tenants when needed, and seeking out top-quality opportunities. The deliberate speed at which we originate reflects purposeful restraint as we work through today's conditions and get the company ready for growth down the road once reforms take shape. Turning to policy, the quarter's standout item was clearly President Trump's executive order instructing the Attorney General to speed up moving cannabis from Schedule I to Schedule III. That's a meaningful and positive federal indication, though it still needs the Department of Justice to act decisively. Getting rescheduling done is essential for ending the onerous 280E tax framework and for enabling further reform that might reopen access to capital, both of which are fundamental to this industry's long-term wellbeing. Like so many others, we're waiting on the DOJ. Until it moves, we'll keep operating carefully in line with the current regulatory landscape and stick with our disciplined, risk-conscious strategy. Looking ahead to 2026, NewLake begins the year with a robust balance sheet. Our cash exceeds our debt. We carry no costly preferred stock and, as far as I know, the lowest leverage ratio among all REITs. We anticipate ongoing headwinds for the cannabis industry until reforms are finally finished. Given that, we'll stay disciplined and wait for the opportunities that will emerge as the industry moves forward. Thanks for being with us, and I'll hand the call over to Anthony now.

Anthony Coniglio executive
#3

Thanks, Gordon, and good morning to all. Our fourth-quarter performance matched what we had anticipated, with AFFO of $0.51 per share and a payout ratio of 85% on that AFFO. Results for the entire year came in above 2024's, which stands out particularly in a market where rivals posted declines in revenue as well as AFFO compared with the prior year. All through 2025, our team stayed dedicated to reducing risks throughout the portfolio, filling vacant spaces and finding quality investment opportunities. That effort has carried over into 2026. Over the year, we completed 2 smaller deals with Cresco Labs, an existing tenant of ours, and we joined forces with Curaleaf and C3, both tenants, to improve how properties performed and to further lower long-term risk within the portfolio. On our prior call, we shared specifics regarding the C3 amendment. As a reminder, though, construction costs that came in above what we expected made the Hartford project less appealing, and we collaborated with our tenant to put together a transaction that gives our shareholders a better balance of risk and reward. On the whole, our portfolio is in a strong position. Our 3 biggest tenants — Curaleaf, Trulieve and Cresco — who collectively account for over 50% of annualized base rent, all posted robust results for 2025, including positive operating cash flow. Curaleaf brought in $1.3 billion of net revenue, achieved a 50% adjusted gross margin and generated $90 million in free cash flow. Trulieve kept showing profitability that leads the industry, with gross margins of 60% and $230 million in free cash flow. Cresco posted sequential gains in gross margins, reaching 52%, pushed out its debt maturities to 2030 and produced more than $70 million of operating cash flow over the year. That said, the wider cannabis sector is still difficult absent federal reform, and we keep managing risk proactively while looking for chances to bolster the portfolio; we are also watching developments at The Cannabist closely, which is still in forbearance with its creditors after defaulting on debt. During the first quarter of 2026, The Cannabist finished selling its San Diego operations, where we lease a dispensary. Wellgreens, the new operator, has taken over that location, and we are happy to welcome them onto our tenant roster. Tied to the transition, we finished a lease amendment through which Wellgreens took on full operational control of the property, and we obtained a 5-year lease extension. This amendment highlights the property's strategic worth inside the cannabis ecosystem, improves long-term cash visibility and shows our disciplined, proactive method of managing assets in the portfolio. The transition additionally cuts our exposure to The Cannabist from 9% to 8% of annualized base rent. Moving to policy. Although federal momentum is heartening, we stay suitably careful until a final rule rescheduling cannabis gets published. Removing 280E by shifting to Schedule III would substantially better long-term cash flow fundamentals for our tenants and, in our opinion, clear the path for further reforms like the SAFER Banking Act and wider expansion at the state level. Also, soon after our previous earnings call, the President signed a continuing resolution that shut the long-standing hemp loophole from the 2018 Farm Bill. That gap in the rules made possible a market spanning the whole country for THC products derived from hemp that cause intoxication, operating beyond systems each state regulates; in our view, this channel without oversight pulled revenue away from operators holding state licenses. Should it take effect in full on the 12th of November this year, as currently planned, prohibiting hemp-derived THC might assist in making pricing more stable and in supporting growth in operator revenue during the second half of 2026 and on into 2027. Taken together, these reforms, rescheduling, and doing away with hemp-derived THC, once they are put in place, could substantially strengthen industry fundamentals and, as a result, the quality of our tenants. It's important to note that we aren't counting on these reforms, and we aren't changing underwriting or how we allocate capital because of expected policy results; regarding properties we have vacant, we keep pushing re-tenanting work forward. Interest is still healthy, and we'll bring investors updates once developments turn tangible. Thoughtful, risk-adjusted choices meant to safeguard long-term shareholder value stay our priority. With that, I'll hand things over to Lisa.

Lisa Meyer executive
#4

Thanks, Anthony. Looking at the whole of 2025, total revenue from our portfolio came to $51.1 million, which was a slight 1.9% gain over the $50.1 million we brought in during the full year of 2024. Several things drove that top-line improvement: rent from the 2 Ohio dispensaries we bought in 2025, a complete year of rent from a property purchased in 2024 for $4 million, a full twelve months of rent tied to improvement allowances we funded during 2024 totaling $15.1 million, and the annual escalators that reliably lift our revenue. Partly working against that gain were vacancies at 2 properties that had been leased to Ayr and 1 property that had been leased to Revolutionary Clinics. Thanks to this modest top-line improvement, we saw a matching rise in net income and AFFO. Net income attributable to common stockholders across the full year of 2025 came to $26.3 million, versus $26.1 million for the full year of 2024. AFFO for the full year of 2025 was $43.8 million, or $2.09 per share, which works out to a 0.3% increase year-over-year. Now turning to the fourth quarter of 2025. Total revenue reached $12.3 million, a slight decline of roughly 1.4% year-over-year; that drop was mostly due to the vacancies I mentioned earlier. In the fourth quarter of 2025, we used the remaining Ayr security deposit of about $408,000 to cover part of the unpaid rent. Reduced rental income plus extra property carrying costs produced matching declines in our quarterly results. Net income attributable to common stock for the 3 months ended December 31, 2025, was $6 million, or $0.29 per share. AFFO in the fourth quarter came to $10.6 million, or $0.51 per share, a 3% decrease versus the same period in 2024. On December 15, 2025, the company declared a fourth quarter cash dividend of $0.43 per share, paid out on January 15, 2026. That dividend equates to an AFFO payout ratio of 85%; across the full year of 2025, our total dividend was $1.72 per share, an AFFO payout ratio of 82%. More recently, our Board of Directors declared the first quarter 2026 cash dividend of $0.43 per share. It is payable on April 15, 2026, to shareholders of record as of March 31, 2026. As of December 31, 2025, our balance sheet is in strong shape, with $433 million in gross real estate assets and just $7.6 million of outstanding debt. Our leverage is still exceptionally low, at 1.6% debt to total gross assets, with a debt service coverage ratio of roughly 78x. On top of that, we face no debt maturities until May of 2027. Liquidity is solid, with $106.3 million available, comprising $23.9 million in cash and $82.4 million of untapped capacity under the revolving credit facility. With that, I'll hand the call to the operator. Operator, please open the line for questions.

Pablo Zuanic analyst
#5

I want to pick up on what was said regarding the Ayr security deposit that got used toward rental income during the fourth quarter. It's really just a simple arithmetic thing as I try to build a model for 1Q. If nothing else changes, how much would that affect the Ayr side? Since, as I understand it, you still put some deposits and escrow toward rental income in 4Q. Could you walk through that and give us the numbers?

Lisa Meyer executive
#6

Sure. That $408,000 works out to slightly more than 1.5 months' worth of rent. So I suppose it comes to roughly...

Anthony Coniglio executive
#7

Yes, that's it. Just the $408,000.

Lisa Meyer executive
#8

Yes.

Pablo Zuanic analyst
#9

Right. Okay. So assuming nothing else shifts — and I realize plenty could — but going off what we currently know, that's the big thing to account for when modeling 1Q, correct? Or are there any expense line items with a different cadence than 4Q? Again, this is just a basic modeling question to get us started.

Lisa Meyer executive
#10

Yes. No, it would only be the $408,000; the property carrying costs are already sitting on the balance sheet — sorry, on the income statement. So they'll simply keep rolling forward.

Pablo Zuanic analyst
#11

All right. Then, Anthony, on that latest IIPR call, they came across as pretty positive, or bullish I suppose, about their capacity to bring in new tenants for facilities. Whether you'd say the same thing, I'm not sure. The way I see it, finding a replacement tenant for the Massachusetts facility that Rev Clinics occupies is dragging on. As for the 2 Ayr properties, in Pennsylvania and Nevada, I'm unclear where things stand on getting new tenants; but if you could — this is a 2-part question. Do you agree with that upbeat view coming from IIPR? And then perhaps give a bit more detail about the timing and the method for re-tenanting, whether to cannabis operators or to parties from outside the industry.

Anthony Coniglio executive
#12

Yes. Thanks for asking, Pablo. We've now been doing this for more than 7 years. We speak with plenty of operators. This industry makes us quite wary. Because of certain things we covered in the prepared remarks — namely that this industry can't get access to regular way capital, and the burdensome 280E taxation on the industry and the way that constrains capital flows to the companies. So although interest in the vacant properties has picked up modestly, we're simply going to stay very cautious. On Massachusetts specifically, I'd note there are certain structural changes to how the state regulates, for instance raising the cap on dispensaries that any single operator may own, and that is among the things generating some renewed interest in the sector. So even though there's some activity around our properties, we won't be putting out LOIs. The only thing we'll put out is actual lease activity. So though I'm cautiously optimistic, we definitely won't adopt a tone here at NewLake suggesting everything is wonderful and we'll have no trouble backfilling these properties. That isn't where we stand.

Gordon DuGan executive
#13

Also, Anthony, let me tack on that I'm on board with every point you made. A slight uptick in activity and in operators' interest toward expansion is showing up, and on all 3 sites we've got things happening. Still, closing a lease at any one of them is a struggle. So, like Anthony mentioned, I'd say we're being quite sensibly careful about putting out any announcement before something actually gets finished.

Pablo Zuanic analyst
#14

That's useful detail, thanks. Alright, so let's turn to Cannabist and Acreage. Once again, I understand there's a limit to what you're able to disclose regarding these businesses. I get that you can see nonpublic information, which means you're unable to discuss it. But when it comes to Cannabist, you mentioned the California asset, which is great. A new operator has taken that on. Still, could you say anything about Cannabist's remaining operations — specifically the cultivation and dispensary in Illinois, and the cultivation and dispensary in Massachusetts? Are those up and running? As an analyst I probably ought to know this, but I don't — are they operating? What detail are you able to provide, whether from the operator or at a broader state level? Same thing for Acreage's cultivation in Massachusetts and Pennsylvania. Anything you can offer, Anthony. From where I sit, those are two...

Anthony Coniglio executive
#15

Based on our understanding, every one of those assets is up and running. Could they have shut down yesterday? Sure. My knowledge is limited to what we've got. Operating those properties isn't something we do. Even so, we believe all of them are currently operating. For anyone who follows this industry, Illinois is clearly a stronger state to run a business in than Massachusetts; and we draw some reassurance from the fact that a very large Canadian company owns Acreage, even though the structure is ring-fenced, but that deal only closed slightly more than 12 months ago, and I believe Canopy perceives significant long-term opportunity in owning and extracting maximum value from a U.S.-based MSO such as Acreage; and so I'd point you to the first quarter dividend announcement and, tied to that, if there were anything material to share, we place great importance on being transparent with our investors. So we'd have put out an announcement. Yet as things stand right now, every one of our tenants is in compliance with their leases. No one is in default as of today.

Gordon DuGan executive
#16

Perhaps I can add a bit more detail there. You've landed on precisely the 2 tenants worth concentrating on. My concern would lean more toward Cannabist and Acreage, and only time will tell how things unfold for each of them; that said, Acreage has paid its rent on time; and as for Cannabist, my sense is much the same so far, yet they've gone into default on their — they're currently under forbearance regarding their senior debt. So that's something we're monitoring very closely.

Pablo Zuanic analyst
#17

Right, thanks. That's useful detail once more. Turning to something else — regarding that Connecticut asset listed as held for sale on your balance sheet, C3, I believe, if I understood the 10-K properly, any sale price above book value flows to C3, while a sale beneath book value means C3 absorbs the loss. Could you confirm that and set me straight — that is, tell me if my reading is mistaken?

Anthony Coniglio executive
#18

That's right, though let me expand on it: when a sale brings in more than market value, there's a value band in which C3 shares, letting them recoup part of the substantial capital they put into the asset; past that band, though, any excess on the asset accrues to NewLake. And your second point stands as well — I'll restate it: should the price fall even $0.01 under our basis, we get 100% reimbursed.

Pablo Zuanic analyst
#19

Understood. Yet suppose the asset goes unsold for 12 months or even 24 — the arrangement stays valid, I'd imagine, correct?

Anthony Coniglio executive
#20

Correct. They remain our tenant and keep paying rent throughout, as they look — as we look — to sell that property.

Pablo Zuanic analyst
#21

Alright, my apologies — I hadn't caught that. So even though that asset is currently listed as held for sale, rent is still coming in and it's up to date. Right.

Anthony Coniglio executive
#22

That's right. Yes.

Pablo Zuanic analyst
#23

Anyway, shifting gears — sorry if this belongs somewhere else in the Q&A queue. Regarding IIPR, on their conference call they said the SEC has served them. I'm not sure of the precise legal wording — subpoena, or investigation. Whenever I hear something like that, my mind goes to whether it says anything about the broader sector, about other companies doing sale-leasebacks. Obviously, if you'd been served, most likely you'd put out a press release about it. Still, my own view is that investigations of this kind aren't necessarily tied to one company alone — the whole industry and its practices could be under the microscope. So for NewLake there might be a very small risk of spillover. That said, if I've got it wrong, tell me.

Anthony Coniglio executive
#24

Not in my view, not at all. To be crystal clear: no investigation is underway involving us. Nothing has come to us by way of SEC inquiries. And from the SEC, no subpoenas have reached us. Beyond that, transparency and how we communicate with investors matter enormously to us. You've seen how we've operated across 5 years — we aim to be extremely candid regarding portfolio problems and regarding how our tenants are doing. Pablo, whether any read-through truly exists here, I'm not sure. If you go by the disclosure — and honestly, that's all any of us can rely on at this point — if you go by the disclosure, it seems to have grown out of the class action lawsuits they faced, which concerned how transparent the company's disclosures were. Class action lawsuits against us? There are none. Being insufficiently transparent in our investor communications? We've never faced that accusation. So a read-through to other sale-leaseback providers — I wouldn't expect one.

Pablo Zuanic analyst
#25

All right. Then for the final question — I realize you've already addressed the policy side, and it's clear there's uncertainty there, even if all of us feel optimistic about both the federal and state levels. Still, could you share a bit more detail about what you're hearing in your talks with operators? Are some of them attempting to position themselves ahead of Virginia or Pennsylvania, which might make the conversations you're having right now more favorable and productive regarding upcoming opportunities for NewLake? In the same way, as you mentioned, if rescheduling happens, your operators' and tenants' credit quality gets better, meaning more business. Yet does all of this news actually turn into more active dialogue with operators in the market, or is that not happening yet? Am I reading too much optimism into the situation at this point?

Anthony Coniglio executive
#26

Yes, it does, though only slightly. What we observed in Florida ahead of the ballot initiative seems comparable — certain operators were ramping up, doing build-out in expectation, while a big majority waited for the real results. In Pennsylvania, I'd describe it as much the same; a few we've heard about are considering expansion and eager for it, while the rest — and that's most of them — are not. So you get a mix. As for us, activity levels have gone up — evaluating new deals rose in the first quarter compared with the fourth quarter. That said, I don't want you walking away thinking it's multiplied by 10 or that we have an enormous pipeline; that's definitely not the case, and honestly that's a positive, since it signals the industry continues to stay disciplined regarding CapEx obligations. After all, even if we provide funding for the real estate portion of any such project, an operator still has to commit a significant amount of equity into a cultivation facility or dispensary — for equipment, staff training, and various other costs required to get those facilities operational. So I believe most people are exercising good judgment and not overcommitting to what might happen. They're researching, holding discussions, but I'd say they're being suitably careful.

Gordon DuGan executive
#27

Absolutely. I'd say it's reasonable to feel somewhat more encouraged about that. We're noticing increased interest from operators in markets such as Massachusetts. In Virginia, hopefully, we're nearing some favorable movement. And Pennsylvania, which you brought up. So yes, it seems like for the first time in quite a while, operators are feeling slightly stronger and more hopeful. The reality is that it's been — this sector has faced difficult conditions; and there does appear to be some signs of early recovery.

Pablo Zuanic analyst
#28

Once more, I'd like to congratulate the team for staying disciplined the whole way through in an extremely difficult market.

Gordon DuGan executive
#29

Craig, apologies that you had to wait so long. Those are good questions, though; that was useful.

Craig Kucera analyst
#30

Yep, they certainly were. Yep, definitely. All right, so I have a handful of follow-ups regarding Cannabist. So I suppose you managed to get that California asset retenanted with no meaningful downtime, clearly. As for the lease terms — I know you said it was a 5-year lease, but regarding the rent, was that roughly in line with what Cannabist had been paying?

Anthony Coniglio executive
#31

One thing to clarify. It isn't a 5-year lease. It's a 5-year lease extension.

Craig Kucera analyst
#32

An extension, then.

Anthony Coniglio executive
#33

Yes, it was indeed an extension. What we did was lengthen the term on that lease, and from an NPV standpoint, as you're aware, securing that extension allowed us to create value. Then there's Cannabist...

Gordon DuGan executive
#34

Anthony, what was the old lease term?

Anthony Coniglio executive
#35

There were roughly 6 years left on it.

Gordon DuGan executive
#36

Got it. Right. So we extended it, clearly, to 11, or approximately that.

Anthony Coniglio executive
#37

Yes, and rental...

Gordon DuGan executive
#38

yes, Go ahead. Sorry, Anthony.

Anthony Coniglio executive
#39

No, no, go ahead, Gordon. Rent was not adjusted.

Craig Kucera analyst
#40

All right, that's useful. And when it comes to the other 4 assets that Cannabist is leasing, could you break down for us how much originates in Massachusetts and how much in Illinois?

Anthony Coniglio executive
#41

It's roughly a 50/50 division. Out in Illinois, we operate a dispensary plus a cultivation site, and in Massachusetts we've got the very same setup.

Craig Kucera analyst
#42

Right, okay. And is it fair to say those leases typically come with your usual, say, 6-month rent deposit attached?

Anthony Coniglio executive
#43

The deposits on those leases differ. 6 months isn't the rule; it fluctuates. In some cases there's somewhat more for cultivation, somewhat less for dispensary. But should those end up in default and we make an announcement, we'll discuss the security deposits tied to them.

Craig Kucera analyst
#44

All right, that's useful. And one last thing regarding Cannabist. Could you help us understand what the rent coverage looks like on those properties? Do they roughly match what you usually see — I believe it's around 3.5% for cultivation and 9% for the dispensary? Are they approximately in that range?

Anthony Coniglio executive
#45

Specific coverage figures at the individual property level aren't something we make public. What I'd say in response is to look at how the state's operating environment works; and I believe you'd see that Illinois, because of how large that market is, because of the more restricted licensing there, offers a stronger operating picture on the whole for cannabis companies in that state compared with, let's say, a Massachusetts; we've discussed repeatedly across the past couple of years how tough things are in Massachusetts, mostly caused by the inability to go vertical due to the cap of 3 on dispensaries, plus the surge of cultivation licenses granted during the last 4 years. In fact, regulators there have noticed, and just recently during a February regulatory commission hearing, the CCC sought feedback regarding a possible moratorium on additional cultivation licenses. That's partly why interest in Massachusetts has been rising, since a moratorium might improve conditions in the state and create stronger floor support for wholesale revenue there, and combine that with the raised cap on dispensary ownership — the legislature passed a bill allowing 6, the House passed one allowing 4, and reconciliation is happening now; those are a few of the tailwinds making people feel somewhat more positive about Massachusetts these days. But to get back to what you asked, operating in Illinois is simpler than operating in Massachusetts.

Craig Kucera analyst
#46

Right, right. That's helpful. Switching topics, in the prior quarter, you said you might consider growing beyond the cannabis industry. Given the somewhat better legislative climate and its momentum, does that perhaps cause you to hold off? Or are you still assessing possibly expanding outside of cannabis?

Anthony Coniglio executive
#47

We keep assessing every opportunity to produce growth for shareholders. So yes, over the quarter, we were assessing opportunities outside of cannabis. And once we believe there's a chance for favorable risk/reward, we'll bring it to our investment committee and in the end, the Board for approval.

Gordon DuGan executive
#48

Absolutely. Let me build on what was just said. There appears to be a certain quiet, favorable trend that would lift the standard for opportunities outside cannabis, thanks to that favorable trend. And nearly every time, the net lease space still delivers the biggest capitalization rates within cannabis. So the standard is a demanding one. Of the other options we have reviewed, a number strike us as appealing, yet they come with smaller returns. That has consistently been the underlying logic behind cannabis sale-leaseback: extremely strong returns paired with greater risk. And I believe we have managed that quite effectively. Even so, the standard remains — that favorable regulatory trend has likely nudged the standard upward, in a subtle manner, for pursuing anything beyond cannabis.

Craig Kucera analyst
#49

Understood. One last item from my side. You brought up how strong the publicly traded firms are — those account for roughly 50% of your portfolio, I believe — and clearly, we're able to examine that, plus there's plenty of transparency regarding what they do. That said, could you address the tenants you have in the private category? Is any erosion showing up in 4-wall coverage, or is anything worrying you on that front?

Anthony Coniglio executive
#50

No. And as you noted, we aren't able to get into their particular profitability, but things are going the way we anticipated. And it isn't a — they're doing well. A few private operators we work with have profit and cash flow profiles that industry participants would be thrilled to have, that kind of financial result. Still, we are — everyone is delivering in line with what we expected.

Anthony Coniglio executive
#51

Excellent. We’re grateful to each of you for being here today. Your ongoing backing means a lot to us, and we’re eager to share fresh updates with you during the months to come. Enjoy your weekend.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete NewLake Capital Partners, Inc. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to NewLake Capital Partners, Inc. earnings transcripts and 132,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.